Celularity Inc. (CELU)
NASDAQ: CELU
· Real-Time Price · USD
3.77
0.16 (4.43%)
At close: Aug 22, 2025, 3:59 PM
3.81
1.20%
After-hours: Aug 22, 2025, 07:47 PM EDT
Celularity Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 18.13M | 9.3M | 12.11M | 14.68M | 12.11M | 3.79M | 2.94M | 3.94M | 4.13M | 4.13M | 3.78M | 5.93M | 4.86M | 10.62M | 3.2M | 2.66M |
Cost of Revenue | 7.34M | 3.88M | 2.12M | 1.64M | 9.61M | 3.6M | 802K | 2M | 5.25M | 7.21M | 3.18M | 4.03M | 2.75M | 2.31M | 1.44M | 1.24M |
Gross Profit | 16.89M | 5.41M | 9.99M | 13.04M | 2.5M | 184K | 2.14M | -21.74M | -1.12M | -3.08M | 597K | 1.91M | 545K | 8.31M | 1.76M | 1.42M |
Operating Income | -9.28M | -11.53M | -10.18M | -7.38M | 13.31M | -99.26M | -42.48M | -63.87M | 17.48M | -5.65M | 4.17M | -41.61M | -14.95M | 10.9M | -60.61M | -44.4M |
Interest Income | 77K | 77K | 67K | 110K | 115K | 23K | 66K | 116K | 210K | 108K | 41K | 6K | 8K | 55K | 129K | 140K |
Pretax Income | -13.29M | -16.1M | -6.49M | -22.01M | 9.56M | -93.88M | -47.95M | -64.02M | 24.45M | 4.78M | 47.84M | -62.87M | -4.02M | 49.94M | -64.48M | -81.54M |
Net Income | -13.29M | -16.1M | -6.49M | -22.01M | 9.55M | -93.88M | -47.95M | -64.02M | 24.43M | 4.8M | 47.83M | -62.87M | -4.04M | 49.94M | -64.48M | -81.54M |
Selling & General & Admin | 16.06M | 12.65M | 15.91M | 14.03M | 13.07M | 10.75M | 12.83M | 13.93M | 19.08M | 14.91M | 15.57M | 16.46M | 13.21M | 21.64M | 28.86M | 7.63M |
Research & Development | 3.83M | 3.92M | 3.8M | 5.84M | -272K | 3.39M | 8.6M | 16.95M | 10.99M | 20.35M | 25.35M | 19.93M | 22.63M | 23.77M | 22.91M | 16.99M |
Other Expenses | n/a | 375K | 456K | 546K | -23.61M | 83.51M | 23.18M | 36.2M | -48.67M | 987K | 546K | 541K | -13.62M | -48M | 10.59M | 21.2M |
Operating Expenses | 20.07M | 16.94M | 20.16M | 20.42M | -10.81M | 99.44M | 44.61M | 65.8M | -18.6M | 35.81M | 41.47M | 38.67M | 15.15M | -2.59M | 62.37M | 45.81M |
Interest Expense | 1.81M | 1.75M | 1.55M | 1.15M | 663K | 971K | 1.1M | 277K | n/a | n/a | n/a | n/a | 759K | 843K | 817K | 752K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 44K | n/a | n/a | n/a | 163K | n/a | n/a | n/a | 252K | n/a | n/a | n/a |
Cost & Expenses | 27.41M | 20.82M | 22.29M | 22.06M | -1.2M | 103.04M | 45.41M | 67.81M | 35.87M | 36.07M | 41.35M | 47.55M | 19.81M | -276K | 63.81M | 47.05M |
Income Tax Expense | n/a | n/a | n/a | n/a | 10K | n/a | n/a | 424K | 13K | -17K | 17K | n/a | 20K | n/a | 43.7K | 43.7K |
Shares Outstanding (Basic) | 22.35M | 21.98M | 21.85M | 21.44M | 17.81M | 18.77M | 17.66M | 15.54M | n/a | 16M | 14.02M | 13.04M | 12.41M | 10.64M | 12.25M | 2.4M |
Shares Outstanding (Diluted) | 22.35M | 21.98M | 21.85M | 21.44M | 17.81M | 18.83M | 17.66M | 15.54M | 15.26M | 15.05M | 15.13M | 13.04M | 12.41M | 12.36M | 12.25M | 2.4M |
EPS (Basic) | -0.58 | -0.73 | -0.3 | -1.03 | 0.54 | -4.98 | -2.72 | -4.12 | n/a | 0.30 | 3.41 | -4.82 | -0.33 | 4.69 | -5.26 | -6.66 |
EPS (Diluted) | -0.58 | -0.73 | -0.3 | -1.03 | 0.54 | -4.98 | -2.72 | -4.12 | 1.60 | 0.30 | 3.20 | -4.82 | -0.33 | 4.00 | -5.26 | -6.66 |
EBITDA | -9.61M | -12.45M | -2.94M | -18.71M | -8.55M | -90.56M | -44.52M | -61.38M | 26.89M | 7.18M | -38.55M | -60.58M | -655K | 53.13M | -48.63M | -78.85M |
EBIT | -11.48M | -14.35M | -4.94M | -20.86M | -10.85M | -92.91M | -46.84M | -63.74M | 24.45M | 4.78M | -40.87M | -62.87M | -3.26M | 50.78M | -50.56M | -80.79M |
Depreciation & Amortization | 1.88M | 1.89M | 2M | 2.16M | 2.3M | 2.34M | 2.32M | 2.34M | 2.44M | 2.39M | 2.32M | 2.28M | 2.61M | 2.35M | 546K | 1.94M |